Biochemical and physiological changes induced by anthrax lethal toxin in J774 macrophage-like cells

PC Hanna, S Kochi and RJ Collier

Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115.

Experiments were performed to probe the mechanism by which Bacillus anthracis Lethal Toxin (LeTx) causes lysis of J774 macrophage-like cells. After incubation of cells with saturating concentrations of the toxin, two categories of effects were found, which were distinguishable on the basis of chronology, Ca(2+)-dependence, and sensitivity to osmolarity. The earliest events (category I), beginning 45 min postchallenge, were an increase in permeability to 22Na and 86Rb and a rapid conversion of ATP to ADP and AMP. Later events (category II) included alterations in membrane permeability to 45Ca, 51Cr, 36Cl, 35SO4, 3H-amino acids, and 3H-uridine, beginning at 60 min; inhibition of macromolecular synthesis, leakage of cellular lactate dehydrogenase and onset of gross morphological changes, at approximately 75 min; and cell lysis, beginning at 90 min. Category II events exhibited an absolute requirement for extracellular Ca2+ and were blocked by addition of 0.3 M sucrose to the medium, whereas category I events were attenuated, but not blocked, by either of these conditions. On the other hand, both ATP depletion and the category II events were blocked in osmotically stabilized medium that was also isoionic for Na+ and K+. This suggests that permeabilization of the plasma membrane to monovalent cations and water may be the earliest of the physiological changes described here. The resulting influx of Na+ and efflux of K+ would be expected to cause depletion of ATP, via increased activity of the Na+/K+ pump.(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 3, Issue 11, pp. 1269-1277, 11/01/1992
Copyright © 1992 by The American Society for Cell Biology

This article has been cited by other articles:

				S. C. Taft and A. A. Weiss Neutralizing Activity of Vaccine-Induced Antibodies to Two Bacillus anthracis Toxin Components, Lethal Factor and Edema Factor Clin. Vaccine Immunol., January 1, 2008; 15(1): 71 - 75. [Abstract] [Full Text] [PDF]

				R. C. Squires, S. M. Muehlbauer, and J. Brojatsch Proteasomes Control Caspase-1 Activation in Anthrax Lethal Toxin-mediated Cell Killing J. Biol. Chem., November 23, 2007; 282(47): 34260 - 34267. [Abstract] [Full Text] [PDF]

				M. T. Albrecht, H. Li, E. D. Williamson, C. S. LeButt, H. C. Flick-Smith, C. P. Quinn, H. Westra, D. Galloway, A. Mateczun, S. Goldman, et al. Human Monoclonal Antibodies against Anthrax Lethal Factor and Protective Antigen Act Independently To Protect against Bacillus anthracis Infection and Enhance Endogenous Immunity to Anthrax Infect. Immun., November 1, 2007; 75(11): 5425 - 5433. [Abstract] [Full Text] [PDF]

				S.-D. Ha, D. Ng, J. Lamothe, M. A. Valvano, J. Han, and S. O. Kim Mitochondrial Proteins Bnip3 and Bnip3L Are Involved in Anthrax Lethal Toxin-induced Macrophage Cell Death J. Biol. Chem., September 7, 2007; 282(36): 26275 - 26283. [Abstract] [Full Text] [PDF]

				R. Mabry, K. Brasky, R. Geiger, R. Carrion Jr., G. B. Hubbard, S. Leppla, J. L. Patterson, G. Georgiou, and B. L. Iverson Detection of Anthrax Toxin in the Serum of Animals Infected with Bacillus anthracis by Using Engineered Immunoassays Clin. Vaccine Immunol., June 1, 2006; 13(6): 671 - 677. [Abstract] [Full Text] [PDF]

				J. F. Hanson, S. C. Taft, and A. A. Weiss Neutralizing Antibodies and Persistence of Immunity following Anthrax Vaccination Clin. Vaccine Immunol., February 1, 2006; 13(2): 208 - 213. [Abstract] [Full Text] [PDF]

				J. E. Comer, C. L. Galindo, A. K. Chopra, and J. W. Peterson GeneChip Analyses of Global Transcriptional Responses of Murine Macrophages to the Lethal Toxin of Bacillus anthracis Infect. Immun., March 1, 2005; 73(3): 1879 - 1885. [Abstract] [Full Text] [PDF]

				H. Barth, K. Aktories, M. R. Popoff, and B. G. Stiles Binary Bacterial Toxins: Biochemistry, Biology, and Applications of Common Clostridium and Bacillus Proteins Microbiol. Mol. Biol. Rev., September 1, 2004; 68(3): 373 - 402. [Abstract] [Full Text] [PDF]

				N. Mohamed, J. Li, C. S. Ferreira, S. F. Little, A. M. Friedlander, G. L. Spitalny, and L. S. Casey Enhancement of Anthrax Lethal Toxin Cytotoxicity: a Subset of Monoclonal Antibodies against Protective Antigen Increases Lethal Toxin-Mediated Killing of Murine Macrophages Infect. Immun., June 1, 2004; 72(6): 3276 - 3283. [Abstract] [Full Text] [PDF]

				A. K. Pickering and T. J. Merkel Macrophages Release Tumor Necrosis Factor Alpha and Interleukin-12 in Response to Intracellular Bacillus anthracis Spores Infect. Immun., May 1, 2004; 72(5): 3069 - 3072. [Abstract] [Full Text] [PDF]

				P. N. Boyaka, A. Tafaro, R. Fischer, S. H. Leppla, K. Fujihashi, and J. R. McGhee Effective Mucosal Immunity to Anthrax: Neutralizing Antibodies and Th Cell Responses Following Nasal Immunization with Protective Antigen J. Immunol., June 1, 2003; 170(11): 5636 - 5643. [Abstract] [Full Text] [PDF]

				S. Liu and S. H. Leppla Cell Surface Tumor Endothelium Marker 8 Cytoplasmic Tail-independent Anthrax Toxin Binding, Proteolytic Processing, Oligomer Formation, and Internalization J. Biol. Chem., February 7, 2003; 278(7): 5227 - 5234. [Abstract] [Full Text] [PDF]

				D. Kobiler, Y. Gozes, H. Rosenberg, D. Marcus, S. Reuveny, and Z. Altboum Efficiency of Protection of Guinea Pigs against Infection with Bacillus anthracis Spores by Passive Immunization Infect. Immun., February 1, 2002; 70(2): 544 - 560. [Abstract] [Full Text] [PDF]

				S. Liu, S. Netzel-Arnett, H. Birkedal-Hansen, and S. H. Leppla Tumor Cell-selective Cytotoxicity of Matrix Metalloproteinase-activated Anthrax Toxin Cancer Res., November 1, 2000; 60(21): 6061 - 6067. [Abstract] [Full Text]

				T. C. Dixon, M. Meselson, J. Guillemin, and P. C. Hanna Anthrax N. Engl. J. Med., September 9, 1999; 341(11): 815 - 826. [Full Text] [PDF]

				G. Tang and S. H. Leppla Proteasome Activity Is Required for Anthrax Lethal Toxin To Kill Macrophages Infect. Immun., June 1, 1999; 67(6): 3055 - 3060. [Abstract] [Full Text] [PDF]

				M. Varughese, A. V. Teixeira, S. Liu, and S. H. Leppla Identification of a Receptor-Binding Region within Domain 4 of the Protective Antigen Component of Anthrax Toxin Infect. Immun., April 1, 1999; 67(4): 1860 - 1865. [Abstract] [Full Text] [PDF]

				S. E. Hammond and P. C. Hanna Lethal Factor Active-Site Mutations Affect Catalytic Activity In Vitro Infect. Immun., May 1, 1998; 66(5): 2374 - 2378. [Abstract] [Full Text] [PDF]

				P. Gupta, S. Batra, A. P. Chopra, Y. Singh, and R. Bhatnagar Expression and Purification of the Recombinant Lethal Factor of Bacillus anthracis Infect. Immun., February 1, 1998; 66(2): 862 - 865. [Abstract] [Full Text] [PDF]

				S. Liu, T. H. Bugge, and S. H. Leppla Targeting of Tumor Cells by Cell Surface Urokinase Plasminogen Activator-dependent Anthrax Toxin J. Biol. Chem., May 18, 2001; 276(21): 17976 - 17984. [Abstract] [Full Text] [PDF]